Financial News
Articles published by Telix Pharmaceuticals Limited
Telix H1 2025 Results: Investor Webcast Notification
July 29, 2025
Telix Reports $204M Revenue, Up 63% YOY
July 22, 2025
Gozellix Receives Permanent HCPCS Code
July 09, 2025
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
April 28, 2025
Telix Reports US$186M Q1 Revenue, Up 62% YOY
April 22, 2025
Telix Appoints Paul Schaffer as Chief Technology Officer
April 07, 2025
Anne Whitaker Appointed as Non-Executive Director
April 03, 2025
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
March 21, 2025
Telix Adds Lead-212 Isotope Production Capability
March 12, 2025
Illuccix® Approved in the United Kingdom
February 12, 2025
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
Illuccix® Receives European Approval
January 16, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
